The term ‘Bio/blood compatibility’ is generally used to indicate the properties of polymeric materials that do not cause adverse effects when in contact with components of living organisms, such as ...
Astellas Pharma is to buy bioelectronic medical devices firm iota Biosciences in a deal worth up to $429m, building on a previous research partnership. In August last year the companies began a joint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results